Cencora Cash Flow Statement
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cencora free cash flow
In fiscal 2025, Cencora generated $3.88 billion of operating cash flow and spent $668.0 million on capital expenditures. That left free cash flow of $3.21 billion, a free-cash-flow margin of 1.0% of revenue. Free cash flow was up 7.0% from the prior year's $3.00 billion.
Cencora returned $872.6 million to shareholders: $437.1 million in dividends and $435.5 million in share repurchases, equal to 27% of free cash flow. Free cash flow covered dividend payments 7.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Cencora cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-09-30 | FY 20242024-09-30 | FY 20232023-09-30 | FY 20222022-09-30 | FY 20212021-09-30 | FY 20202020-09-30 | FY 20192019-09-30 | FY 20182018-09-30 | FY 20172017-09-30 | FY 20162016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.57B | 1.52B | 1.73B | 1.67B | 1.54B | -3.40B | 854.13M | 1.62B | 364.48M | 1.43B |
| Net Income growth (YoY) | +3.20% | -12.31% | +3.96% | +7.89% | — | -498.01% | -47.14% | +343.34% | -74.47% | — |
| Depreciation & Amortization | 1.05B | 1.09B | 963.90M | 693.89M | 505.17M | 391.06M | 462.41M | 465.13M | 397.60M | 364.74M |
| Stock-Based Compensation | 147.96M | 148.00M | 124.62M | 93.40M | 99.59M | 74.41M | 58.87M | 62.32M | 62.21M | 64.99M |
| Change in Working Capital | 653.25M | 1.01B | 1.47B | 641.30M | 20.56M | 31.92M | 145.70M | 121.35M | 458.86M | 902.11M |
| Operating Cash Flow | 3.88B | 3.48B | 3.91B | 2.70B | 2.67B | 2.21B | 2.34B | 1.41B | 1.50B | 3.18B |
| Capital Expenditures | -667.98M | -487.17M | -458.36M | -496.32M | -438.22M | -369.68M | -310.22M | -336.41M | -466.40M | -464.62M |
| Investing Cash Flow | -4.98B | -618.10M | -2.60B | -368.44M | -6.14B | -379.87M | -375.83M | -1.11B | -498.04M | -3.17B |
| Dividends Paid | -437.08M | -416.17M | -398.75M | -391.69M | -366.65M | -343.58M | -338.97M | -333.04M | -320.27M | -288.48M |
| Share Repurchases | -435.47M | -1.49B | -1.18B | -483.70M | -82.15M | -420.45M | -674.03M | -639.24M | -329.93M | -2.27B |
| Debt Issued | 4.51B | 688.32M | 157.55M | 155.19M | 3.17B | 599.48M | 506.95M | 1.31B | 0 | 1.00B |
| Debt Repaid | -1.28B | -662.52M | -811.35M | — | -835.31M | -598.45M | -510.86M | -681.00M | -750.00M | -800.00M |
| Financing Cash Flow | 2.25B | -2.33B | -2.22B | -1.75B | 1.95B | -603.62M | -1.09B | -242.87M | -1.31B | 565.07M |
| Net Change in Cash | 1.10B | 544.99M | -840.65M | 523.41M | -1.53B | 1.22B | 881.68M | 57.40M | -306.72M | 574.39M |
| Free Cash Flow | 3.21B | 3.00B | 3.45B | 2.21B | 2.23B | 1.84B | 2.03B | 1.07B | 1.04B | 2.71B |
This table shows 10 annual periods of Cencora's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow COR's reporting calendar. What is a cash flow statement?